Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA-3 localization shapes lymphocyte function.

Cell reports·2026
Same author

Modeling immune responses of cattle to <i>Mycobacterium bovis</i> using magnetic bioprinted granulomas.

mSphere·2025
Same author

Sex Differences in Vaccine-Induced Immunity and Protection Against Mycobacterium tuberculosis.

The Journal of infectious diseases·2025
Same author

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations.

Acta paediatrica (Oslo, Norway : 1992)·2025
Same author

The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture Conversion.

Pathogens & immunity·2025
Same author

Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth.

eLife·2024

Related Experiment Video

Updated: May 22, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Tuberculosis vaccine development: strength lies in tenacity.

Stefan H E Kaufmann1

  • 1Max Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany. Kaufmann@mpiib-berlin.mpg.de

Trends in Immunology
|May 8, 2012
PubMed
Summary

Novel tuberculosis (TB) vaccines show promise in reducing bacterial load in mice but don't eliminate infection. Further research is needed to understand immune mechanisms for developing more effective vaccines that prevent or abolish TB infection.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

Related Experiment Videos

Last Updated: May 22, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Significant advancements in novel tuberculosis (TB) vaccine development over the past decade.
  • Current TB vaccine candidates in mice reduce bacillary load, indicating control but not complete eradication of infection.
  • The precise immune mechanisms conferring vaccine efficacy remain incompletely understood.

Purpose of the Study:

  • To investigate the immune mechanisms underlying the efficacy of novel tuberculosis (TB) vaccine candidates.
  • To guide the development of next-generation TB vaccines by understanding how to induce the most effective immune responses.
  • To analyze immune responses in diverse human populations, including TB patients, latently infected individuals, and clinical trial participants.

Main Methods:

  • Evaluation of immune responses induced by novel TB vaccine candidates in murine models.
  • Assessment of bacillary load reduction as a measure of vaccine efficacy.
  • Comparative analysis of immune responses across different human cohorts (patients, latent infections, vaccine trial participants).

Main Results:

  • All tested vaccine candidates in mice elicited immune responses that reduced bacterial burden.
  • Observed reduction in bacillary load signifies infection control rather than sterilization.
  • Partial understanding of the immune correlates of protection for current TB vaccines.

Conclusions:

  • Further basic research is crucial to elucidate the immune mechanisms required for sterilizing TB immunity.
  • Understanding immune responses in diverse human populations is essential for refining vaccination strategies.
  • The ultimate goal is to develop TB vaccines that not only prevent disease but also prevent or eliminate infection entirely.